Rating: HOLD
HOLD (5-tier) · mature cash generator · conviction: medium
| Metric | Value |
|---|---|
| Current Price | $115 |
| Triangulated Fair Value | $111 (-3% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $107 (-7% vs spot · 12m PWEV) |
| Forward P/E | 6.5x |
| Market Cap | $18B |
| 52-Week Range | $75–$141 |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Investment Committee Summary
| Rating | HOLD · HOLD (5-tier) |
| Classification · conviction | mature cash generator · medium |
| Triangulated fair value | $111 (-3% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $107 (-7% vs spot · 12m PWEV) |
| Next catalyst | 2026-08-05 — Quarterly earnings |
| Primary thesis-break | TTM revenue ($B) < 6.7 (2 consecutive prints) |
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies -7% vs spot
- Monte Carlo median implies -14% vs spot
- DCF fair value implies +4% vs spot — but this is terminal-value sensitive (exit-multiple $120 vs Gordon $241, 101% apart), so it carries less weight
- Bear case (Structural — Nutrient Oversupply / Demand Reset) downside is -76% vs spot
- Net: reward/risk of 0.0× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Investment Thesis
At $108.26 (26 June 2026) CF trades on 6.1x forward earnings and 4.7x EV/EBITDA against a peer-median forward P/E of 18.8x. The market is not paying mid-cycle for these earnings; it is treating current nitrogen profitability as peak and pricing in the fade. The engine largely agrees rather than disputes this. The probability-weighted target of $106.56 sits 1.6% below spot, Monte Carlo puts the probability of the fair value clearing the current price at 42.8%, and the book carries a 42% weight on the commodity-glut state, including a 24% structural scenario worth $27.97 — below the 52-week low of $74.71. The offsetting anchors are the DCF at $120 and the mid-cycle scenario at $110.76, which say spot is roughly fair if prices normalise rather than reset. HOLD follows: no margin of safety in either direction. The most damaging risk is the capital programme — FY2025 capex of $0.95B is ramping into the Blue Point build while incremental ROIC of 7.2% sits below the 9.5% WACC, so the growth spend can destroy value even if nitrogen prices hold.
The dashboard below is the whole argument on one page: spot ($115) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural scenario carries the largest single bear weight at 24% for a reason. Global urea and ammonia capacity additions are running ahead of demand growth, and the Henry Hub cost advantage underwriting CF's 47.3% operating margin narrows whenever European gas normalises. In that state prices and volumes fall together: the path assumes revenue down 20% on a 22.9% operating margin, with the multiple compressing to 4x as the market reclassifies current earnings as unrepeatable. Roughly $7 of EPS on that arithmetic supports a $28 share price, below the 52-week low. Meanwhile the Blue Point build keeps absorbing capital at a 7.2% incremental return against a 9.5% WACC, so the balance sheet cushions less than the $1.58B net-debt figure suggests. Every prior nitrogen downcycle has followed this pattern.
Key Debate
P/E Multiple explains 78% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.50 vs analyst floor +0.00 → delta +0.50 (n=26 mgmt / 20 Q&A; 73th pctile across the S&P book, z +0.7).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.50 | +0.00 | +0.50 |
| 2025Q4 | +0.54 | +0.00 | +0.54 |
| 2025Q3 | +0.63 | +0.04 | +0.60 |
| 2025Q2 | +0.36 | +0.00 | +0.36 |
News (last 365d, 1000 articles): avg ticker sentiment +0.17 (bullish 25% / bearish 5%)
Scenario Analysis
The tree runs from a structural 'Structural — Nutrient Oversupply / Demand Reset' downside ($28) to a 'Spike — Supply Shock (gas / geopolitics)' bull case ($244); the probability-weighted blend (PWEV $107) is -7% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Nutrient Oversupply / Demand Reset | 24% | $28 | -76% |
| Downturn — Price Trough | 18% | $60 | -47% |
| Base — Mid-Cycle Nutrient Prices | 32% | $111 | -4% |
| Upcycle — Tight Nutrient Balance | 18% | $189 | +64% |
| Spike — Supply Shock (gas / geopolitics) | 8% | $244 | +113% |
| Probability-Weighted (PWEV) | — | $107 | -7% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Nutrient Oversupply / Demand Reset (24%, $28). Structural impairment — nutrient glut / demand reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 27.97; probability: 0.24.
- Downturn — Price Trough (18%, $60). Cyclical downturn — nitrogen/potash/phosphate prices + natural-gas cost + crop demand weakens for 1–2 years before normalising. Drivers — implied_target: 60.43; probability: 0.18.
- Base — Mid-Cycle Nutrient Prices (32%, $111). Mid-cycle — normalised nitrogen/potash/phosphate prices + natural-gas cost + crop demand; disciplined capital allocation; steady returns. Drivers — implied_target: 110.76; probability: 0.32.
- Upcycle — Tight Nutrient Balance (18%, $189). Upside — supply shock / tight balance lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 188.84; probability: 0.18.
- Spike — Supply Shock (gas / geopolitics) (8%, $244). Upside tail — sustained tight conditions or a structural re-rate on supply shock / tight balance. Drivers — implied_target: 244.22; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $99 | -14% |
| Peer P/E re-rate | multiple | $335 | +191% |
| Peer EV/Revenue re-rate | multiple | $104 | -10% |
| Scenario PWEV | multiple | $107 | -7% |
| DCF (5-year + terminal) | cash flow + terminal × | $120 | +4% |
| Triangulated (weighted) | — | $111 | -3% |
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
peer P/E re-rate excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $99 and 37% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (78% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 9.5%, 5x terminal FCF multiple → $120. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 18.84x) implies $335. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is 221% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Fertilizers (N / P / K) | $7.4B | 100% | 2% | 47% | $3.5B | 6x | 8% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | nitrogen/potash/phosphate prices + natural-gas cost + crop demand |
| net_debt_or_cash_b | -1.58 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.08 |
| div_yield | 0.0194 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | nutrient glut / demand reset |
| upside | supply shock / tight balance |
Industry Context — Materials — Commodity
This name sits in the Materials — Commodity as a fertilizer. nitrogen/potash/phosphate prices + natural-gas cost + crop demand Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: DOW (commodity_chem) · LYB (commodity_chem) · ALB (lithium) · CF (fertilizer) · MOS (fertilizer)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Commodity Glut — Oversupply / Demand Reset | 42% | 42% | |
| Mid-Cycle — Normalised Prices | 32% | 32% | |
| Tight Market — Upcycle / Spike | 26% | 26% |
Mapping note: name-level 'Structural — Nutrient Oversupply / Demand Reset' (24%) + 'Downturn — Price Trough' (18%) map to cluster Commodity Glut — Oversupply / Demand Reset (42%); name-level 'Upcycle — Tight Nutrient Balance' (18%) + 'Spike — Supply Shock (gas / geopolitics)' (8%) map to cluster Tight Market — Upcycle / Spike (26%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.
On the cluster's key downside — Commodity Glut — Oversupply / Demand Reset () — this name implies 42% vs the cluster house view of 42% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The commodity cycle is the shared macro driver. Driver — commodity-chemical / nutrient / lithium price cycle + feedstock costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $8B | $3B | $1B | $1B | $3B | $2B |
| FY+2 | $8B | $4B | $1B | $1B | $3B | $2B |
| FY+3 | $8B | $4B | $1B | $1B | $3B | $2B |
| FY+4 | $8B | $4B | $1B | $1B | $3B | $2B |
| FY+5 | $8B | $4B | $1B | $1B | $3B | $2B |
| Terminal | — | — | — | — | $3B × 5x | $10B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 8% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 9.5% · Σ PV(FCF) $10B + PV(terminal) $10B = EV $20B; + net cash → equity $19B ÷ diluted shares 0.15B = $120/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $241/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 4% vs WACC 10% → below WACC — the incremental build is value-dilutive.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| CTVA | 3.072x | 22.83x | 5% | 24% |
| MOS | 0.997x | 22.27x | 2% | 1% |
| BALL | 1.706x | 15.41x | 3% | 9% |
| ALB | 3.578x | 13.81x | 5% | 25% |
| Median | 2.3890000000000002x | 18.84x | — | — |
Peer-median fwd P/E → $335; EV/Rev → $104.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $120 | 47% | $56 |
| Scenario PWEV | $107 | 33% | $36 |
| Monte Carlo median | $99 | 20% | $20 |
| Triangulated | — | 100% | $111 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 3.5x | 4.2x | 5.0x | 5.8x | 6.5x |
|---|---|---|---|---|---|
| 8% | $109 | $118 | $129 | $140 | $150 |
| 8% | $105 | $114 | $124 | $135 | $144 |
| 10% | $101 | $110 | $120 | $130 | $139 |
| 10% | $97 | $105 | $115 | $125 | $133 |
| 12% | $94 | $102 | $111 | $120 | $128 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $98 | $102 | $106 | $109 | $113 |
| -1.5pp | $105 | $109 | $112 | $116 | $120 |
| +0.0pp | $111 | $115 | $120 | $124 | $128 |
| +1.5pp | $118 | $123 | $127 | $132 | $136 |
| +3.0pp | $126 | $131 | $135 | $140 | $145 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Revenue CAGR ±3pp | $106 | $135 | $30 |
| Terminal × ±15% | $110 | $129 | $19 |
| Op margin ±3pp | $111 | $128 | $17 |
| Capex intensity ±15% | $112 | $127 | $15 |
| WACC ±1pp | $115 | $124 | $9 |
Company lever — SoP/share vs Fertilizers (N / P / K) multiple (AI re-rating) (base 6x)
| Multiple | 4.2x | 5.1x | 6.0x | 6.9x | 7.8x |
|---|---|---|---|---|---|
| SoP/share | $192 | $235 | $278 | $321 | $365 |
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $124 (+8% vs spot · street) |
| House target | $107 (-13.9% vs street) |
| Sell-side coverage | 21 analysts (SB 3 / B 3 / H 12 / S 2 / SS 1; net score 0.12) |
| Consensus FY EPS | $11.06; house above (+60.5%) |
| Consensus FY revenue | $7.3B; house above (+4.3%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $0.9B — modestly levered |
| Net debt / EBITDA | 0.26x |
| Interest coverage (EBIT / interest) | 15.4x |
| Current ratio | 3.37x |
| Lease obligations | $0.4B |
| Cash & ST investments | $3.1B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $1.8B |
| Buybacks / dividends | $1.4B / $0.3B |
| Total shareholder yield | 9.6% |
| Payout as % of FCF | 94.6% |
| Reinvestment (capex / OCF) | 34.5% |
| SBC as % of FCF | 2.5% |
| Allocation stance | returns-heavy |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 24.4% |
| FCF conversion (FCF / net income) | 100.2% |
| FCF yield | 10.1% |
| Capex intensity (capex / revenue) | 12.8% |
| FCF − SBC (diagnostic) | $1.8B |
| Capex split (maint / growth) | 60% / 40% — Capital-intensive commodity producer; plant turnarounds and sustaining capex are the majority, with a rising growth slice funding the Donaldsonville CCS/low-carbon-ammonia build and capacity debottlenecking. Growth capex is optionality on the clean-ammonia thesis, not the base nitrogen earnings. |
Accounting quality: SBC 0.6% of revenue; cash conversion (OCF/NI) 153% — cash-backed.
Catalyst Calendar
- 2026-08-05 (~28d) — Quarterly earnings — est. EPS $5.71 (AV EARNINGS_CALENDAR)
- 2026-09-30 (~84d) — New global nitrogen-capacity commissioning / export-policy read (China, Russia) (authored)
- 2026-11-30 (~145d) — Blue/green-ammonia (Donaldsonville CCS + low-carbon ammonia) project FID/offtake milestone (authored)
- 2027-04-15 (~281d) — Spring-planting nitrogen-application demand and North American gas-vs-TTF spread read (authored)
Forecast Track Record
- EPS surprise: beat 87.5% of the last 8 quarters; average surprise +21.6%.
Competitive Moat
Narrow moat. CF's moat is a structural feedstock-cost advantage — low-cost North American natural gas and world-scale, well-located nitrogen plants — but nitrogen is a global commodity with no pricing power at the product level, so the moat is narrow and the terminal multiple should stay low (high-single-digit EV/EBITDA / low-teens P/E); the ~6x forward P/E already prices the current nitrogen margin as peak, and if the gas-cost advantage narrows the multiple has little room to compress further but earnings do.
Moat sources:
- Low-cost feedstock position: North American Henry Hub gas vs European TTF-linked marginal producers sets a durable cost-curve advantage
- World-scale, tidewater/pipeline-connected ammonia-urea-UAN plants with logistics and export access
- Nitrogen cost-curve position (bottom-quartile cash cost) that keeps CF profitable when marginal producers idle
- ABSENCE of product pricing power — nitrogen is a fungible global commodity priced off the marginal (gas-cost-set) producer
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| Section 45Q carbon-capture / clean-hydrogen tax credits underpinning the low-carbon ammonia optionality | medium (~35%) | medium - 45Q durability is a swing factor for the clean-ammonia upside but not the base nitrogen business; ~7% of FV | 12-24m |
| US/EU trade policy on nitrogen imports (antidumping duties, Russian/Trinidad supply) and carbon border adjustment (CBAM) | medium (~40%) | medium - duties/CBAM can support North American nitrogen prices; ~6% of FV | 12-24m |
| Environmental/emissions and nitrogen-runoff regulation on ammonia production and application | low (~20%) | low - compliance cost is manageable for a low-cost producer; ~3% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Nutrient Oversupply / Demand Reset | New global nitrogen capacity (Middle East, Russia normalisation) plus a narrowed North American gas-cost advantage floods the market; nitrogen prices sit at trough for an extended period and both earnings and the multiple compress below the 52-week low. | A durable supply glut erases the cost-advantage rent that supports the equity. |
| Downturn — Price Trough | A cyclical nitrogen price trough on soft grain prices/planted acreage for 1-2 years before rebalancing. | The trough extends into a structural oversupply as new capacity commissions. |
| Base — Mid-Cycle Nutrient Prices | Nitrogen prices normalise mid-cycle, North American gas stays cheap relative to TTF, and CF's cost-curve position sustains a mid-cycle margin. | The market is pricing current profitability as peak, so mean-reversion is to the downside. |
| Upcycle — Tight Nutrient Balance | Tight global nitrogen balance on strong agricultural demand and constrained supply lifts prices and margins above mid-cycle. | High prices incentivise the new capacity that reverses the tightness. |
| Spike — Supply Shock (gas / geopolitics) | A European gas spike or geopolitical supply disruption idles marginal producers, driving a nitrogen-price spike and windfall margins for the low-cost producer. | Windfall pricing is transient and mean-reverts hard once the shock passes. |
What the Market Is Pricing In
At the current price, the market pays 10.4× forward EPS, vs the house DCF terminal 5.0×, and a peer median 18.84×. The house DCF sits 4% above spot, so the market is pricing in less than the house case — roughly 0.5pp of revenue CAGR.
Variant perception: the house view is below-consensus, and the thesis is primarily growth-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 7.3 | 7.6 | High |
| EPS | 11.1 | 17.8 | Medium |
| Target price | 123.8 | 106.6 | Medium |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| CTVA | 22.83× | 5% | 24% | broad | 25% |
| MOS | 22.27× | 2% | 1% | broad | 25% |
| BALL | 15.41× | 3% | 9% | broad | 25% |
| ALB | 13.81× | 5% | 25% | broad | 25% |
Quality-weighted forward P/E: 18.6× (simple median 18.84×). Direct peers count 100%, segment 50%, broad 25%.
Valuation-anchor screen: DCF (Gordon) (valid but extreme (>100% over median)); Peer (fwd P/E) (valid but extreme (>100% over median)). Anchor median 119.6. Extreme/excluded anchors carry no headline weight.
Historical-range cross-check: 52-week range $75–$141, centre $103 (-11% vs spot); spot sits at the 60th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $111 (-3% vs spot · triangulated FV) |
| Downside to bear case (Structural — Nutrient Oversupply / Demand Reset) | $28 (-76% vs spot · bear scenario) |
| Reward/risk ratio | 0.0× |
| Margin of safety (FV vs spot) | -3% |
| P(price > spot) — Monte Carlo | 37% |
Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Spike — Supply Shock (gas / geopolitics)): $244.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 9.5% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 5× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (30.0); Terminal × ±15% (19.0); Op margin ±3pp (17.0); Capex intensity ±15% (15.0); WACC ±1pp (9.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $7.4B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $7.6B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $11.0633 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.155B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $0.896B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 9.5% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 5× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-07-08 | Price, market cap, EV, 52-week range, forward P/E | Alpha Vantage 2026-06-26 |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-07-08 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-07-08 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-07-08 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-07-08 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-07-08 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-07-08 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-07-08 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Load-Bearing Assumptions
DCF: WACC 10%, terminal multiple 5×, FY+5 revenue $8B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- TTM revenue ($B) < 6.7 (2 consecutive prints → Commodity Glut — Oversupply / Demand Reset). Midpoint between the base path (~$7.55B on FY guidance of $7.6B) and the downturn path (revenue −10% on $7.4B TTM ≈ $6.66B). Two prints below $6.7B says realised nitrogen pricing has left mid-cycle and the 32% base weight is too high.
- Reported operating margin (%) < 41.0 (2 consecutive prints → Commodity Glut — Oversupply / Demand Reset). Midpoint of the base-path 47.4% operating margin and the downturn-path 35.2%. Sustained prints below 41% indicate the Henry Hub cost advantage is being competed away faster than the mid-cycle scenario assumes.
- FY capital-expenditure guidance ($B) > 1.6 (single event → Commodity Glut — Oversupply / Demand Reset). The authored schedule peaks at $1.4B for the Blue Point build. A guide above $1.6B while incremental ROIC (7.2%) already sits below the 9.5% WACC means the growth programme is destroying value and the DCF anchor of $120 is overstated.
- Share buyback activity in the quarter ($M repurchased) < 50 (2 consecutive prints → Commodity Glut — Oversupply / Demand Reset). CF repurchased $1.38B of equity in FY2025 against $1.58B net debt. Two quarters of near-zero buybacks signals management is conserving cash for the downcycle it sees coming — a disclosed-behaviour tell that precedes the earnings reset.
Fact / Inference / Speculation
- FACT: Spot $115; 52-week range $75–$141; engine rating HOLD; base-case target $107 (-7%). (source: Alpha Vantage 2026-06-26, 8 July 2026)
- INFERENCE: Triangulated FV $111 (-3% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits above the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Recommendation: HOLD
Balanced: triangulated fair value $137 (+20% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.